Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/16003
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSong, Tao-
dc.contributor.authorDong, Qunming-
dc.contributor.authorSankoh, Abdul J.-
dc.contributor.authorMOLENBERGHS, Geert-
dc.date.accessioned2013-11-21T10:13:40Z-
dc.date.available2013-11-21T10:13:40Z-
dc.date.issued2013-
dc.identifier.citationJOURNAL OF BIOPHARMACEUTICAL STATISTICS, 23 (6), p. 1281-1293-
dc.identifier.issn1054-3406-
dc.identifier.urihttp://hdl.handle.net/1942/16003-
dc.description.abstractIn longitudinal clinical trials for drug development, the study objective is often to evaluate overall treatment effect across all visits. Despite careful planning and study conduct, the occurrence of incomplete data cannot be completely eliminated. As a direct likelihood method, the mixed-effects model for repeated measures (MMRM) has become one of the preferred approaches for handling missing data in such designs. MMRM is a full multivariate model in nature, which avoids potential bias as a predetermined model, and operates in a more general missing-at-random (MAR) framework. However, if treatment effect is constant over time, overparameterization of treatment by time interaction in MMRM could result in loss of power. In this article, we utilize MMRM estimates and propose an optimal weighting method for combining visit-specific estimates to maximize the power under MAR mechanism. For a special case where the underlying covariance is compound symmetry, we show that the optimal weighting method is asymptotically equal to MMRM. In other words, MMRM has optimal power under this special case. When the underlying covariance is of an unstructured pattern, the optimal weighting method has increased power under MAR and missing-not-at-random (MNAR) mechanisms, and can lead to bias reduction under MNAR. This is especially true when the variance is greater at later time point, which could lead to a smaller weight. We present practical examples using the optimal weighting method to analyze two cystic fibrosis clinical trial data sets.-
dc.language.isoen-
dc.subject.otherbias reduction; MMRM; optimal weight; overall treatment effect; power-
dc.titleEvaluation of overall treatment effect in MMRM-
dc.typeJournal Contribution-
dc.identifier.epage1293-
dc.identifier.issue6-
dc.identifier.spage1281-
dc.identifier.volume23-
local.bibliographicCitation.jcatA1-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1080/10543406.2013.834918-
dc.identifier.isi000325786600005-
item.fulltextWith Fulltext-
item.contributorSong, Tao-
item.contributorDong, Qunming-
item.contributorSankoh, Abdul J.-
item.contributorMOLENBERGHS, Geert-
item.fullcitationSong, Tao; Dong, Qunming; Sankoh, Abdul J. & MOLENBERGHS, Geert (2013) Evaluation of overall treatment effect in MMRM. In: JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 23 (6), p. 1281-1293.-
item.validationecoom 2014-
item.accessRightsOpen Access-
crisitem.journal.issn1054-3406-
crisitem.journal.eissn1520-5711-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
JBS_Jan 2012.pdfPeer-reviewed author version274.32 kBAdobe PDFView/Open
song2013.pdf
  Restricted Access
Published version141.9 kBAdobe PDFView/Open    Request a copy
Show simple item record

SCOPUSTM   
Citations

2
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

2
checked on May 16, 2024

Page view(s)

84
checked on Sep 7, 2022

Download(s)

402
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.